The treatment of children's diabetes requires special care, since from an early age, children must understand what their disease consists of, identify which foods can consume and remember fulfilling their medication.Something that parents should not lose sight of is to notify the school staff the health status of the child and what measures to take in case serious complications such as hypoglycemia are presented.
The role of the school for the integration of the child with diabetes is decisive, favoring non -discriminatory coexistence situations, promoting autonomy habits and enabling the acquisition of knowledge that will help the child's development in all its potentialities.It must be made clear that it is not about asking for a different treatment, but that everyone knows what to do in case of emergency and what activities the student should do for their health care.
The endocrinologist, Danniela Wildman, stressed that glycemia monitoring is essential in the care of pediatric patients with diabetes.Depending on what the measurement reflects, it can be evaluated whether the blood sugar level is well controlled, if it is high and it is necessary to administer insulin, or if on the contrary, it is very low and it is convenient to give it a juice or some sweet.In this regard, he pointed out that when the child has good metabolic control, the disease should not affect his school life.
The president of the Zulia chapter of the Endocrinology Society specified that in cases of children with type I diabetes, the treatment must combine diet, exercises and insulin administration.He also explained that there are different types of insulin, according to the patient's specific needs: prolonged action to maintain the basal level and others of rapid action that help metabolize the glycemia peaks that are generated after eating.
Not all insulins are suitable for administering in children under two years, because the vulnerability of these children makes the application of high security standards necessary.Recently the United States Drug and Food Administration (FDA) approved the indication of an insulin analogue for this age group.
